Terms: = Breast cancer AND RAF1, Raf-1, 5894, P04049, ENSG00000132155, c-Raf, CRAF AND Clinical Outcome
5 results:
1. The targeted inhibition of Hsp90 by a synthetic small molecule, DPide offers an effective treatment strategy against TNBCs.
Oh YJ; Park SY; Seo YH
Oncol Rep; 2018 Apr; 39(4):1775-1782. PubMed ID: 29436674
[TBL] [Abstract] [Full Text] [Related]
2. BAG-1 as a biomarker in early breast cancer prognosis: a systematic review with meta-analyses.
Papadakis ES; Reeves T; Robson NH; Maishman T; Packham G; Cutress RI
Br J Cancer; 2017 Jun; 116(12):1585-1594. PubMed ID: 28510570
[TBL] [Abstract] [Full Text] [Related]
3. Proteomic modulation in breast tumors after metformin exposure: results from a "window of opportunity" trial.
Kalinsky K; Zheng T; Hibshoosh H; Du X; Mundi P; Yang J; Refice S; Feldman SM; Taback B; Connolly E; Crew KD; Maurer MA; Hershman DL
Clin Transl Oncol; 2017 Feb; 19(2):180-188. PubMed ID: 27305912
[TBL] [Abstract] [Full Text] [Related]
4. Ras/raf-1/MAPK pathway mediates response to tamoxifen but not chemotherapy in breast cancer patients.
McGlynn LM; Kirkegaard T; Edwards J; Tovey S; Cameron D; Twelves C; Bartlett JM; Cooke TG
Clin Cancer Res; 2009 Feb; 15(4):1487-95. PubMed ID: 19228750
[TBL] [Abstract] [Full Text] [Related]
5. Identification of new genes associated with breast cancer progression by gene expression analysis of predefined sets of neoplastic tissues.
Cimino D; Fuso L; Sfiligoi C; Biglia N; Ponzone R; Maggiorotto F; Russo G; Cicatiello L; Weisz A; Taverna D; Sismondi P; De Bortoli M
Int J Cancer; 2008 Sep; 123(6):1327-38. PubMed ID: 18561318
[TBL] [Abstract] [Full Text] [Related]
